Breaking News

Phyton Granted API CEP Certificate

Helps alleviate docetaxel shortage through plant cell fermentation process

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Phyton Biotech, a global supplier of paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its docetaxel anhydrous API. Phyton is the first North America- or Europe-based contract API supplier to be granted a CEP for docetaxel. Phyton’s docetaxel API is not subject to the current shortage of 10-deacetylbaccatin (10-DAB) starting material because it uses paclitax...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters